ICU: Rega marang dodolan SeaStar Medical Holding Corporation

Simbol lan logo merek SeaStar Medical Holding Corporation (ICU)

SeaStar Medical Holding develops advanced blood filtration systems to combat organ failure. The startup is currently implementing direct B2B deliveries of its devices to US intensive care units. Exclusive HDE status from the FDA protects its position in pediatric nephrology. The price-to-sales ratio on this chart helps assess the business's sales valuation, while the 2.10 value confirms the current level of market valuation.

ICU (SeaStar Medical) riwayat Multiplikator P/S saka 15.11.2024 nganti 16.11.2026

Rincian analitis perusahaan SeaStar Medical Holding Corp. (ICU)

Analisis fundamental perusahaan:SeaStar Medical Holding Corp ICU
Produk asli SeaStar Medical Holding Corp

SeaStar Medical Holding generates steady revenue through the sale of consumables for its blood purification systems. This multiple compares the business's market value to its sales volume, reflecting the efficiency of its technology monetization. A time-series analysis of the P/S ratio helps identify whether the asset is overvalued or possesses hidden growth potential. The stability of this indicator confirms the fundamental resilience of the share price as the device network scales.

Karo sapa SeaStar Medical Holding saingan

DXCM (DexCom Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S PEN (penumbrainc.com)|NOVT - Kapitalisasi marang pendapatan|Haemonetics - Multiplikator P/S|Rega marang dodolan Inspire Medical Systems|PRCT: Multiplikator P/S|Rasio kapitalisasi marang pendapatan CNMD|PLSE (Pulse Medical) - Multiplikator P/S|InMode Corp (INMD) - Koefisien rega marang pendapatan|Multiplikator P/S PMI|Kapitalisasi marang pendapatan Surmodics, Inc. SRDX|Multiplikator P/S SENS (senseonics.com)|Multiplikator P/S NeuroPace Inc NPCE|TCMD - Rasio rega marang pendapatan|SNWV: Rasio rega marang pendapatan|Outset Medical Corp (OM) - Rasio rega marang pendapatan|SmartVest - Rasio kapitalisasi pasar marang pendapatan|LNSR (LENSAR Inc) - Multiplikator P/S|Rega marang dodolan AVITA Medical Inc. RCEL|Rasio rega marang pendapatan Profound Medical (PROF)|Baird Medical Corp (BDMD) - Multiplikator rega marang pendapatan|EDAP TMS SA - Kapitalisasi marang pendapatan|Multiplikator P/S Bovie Medical APYX|IceCure Medical Ltd. - Multiplikator P/S|Koefisien rega marang pendapatan Pulmonx LUNG|TELA Bio (TELA) - Rasio rega marang pendapatan|Rasio rega marang dodolan CTSO (CytoSorbents Corp.)|Rasio rega marang pendapatan sensushealthcare.com|Kapitalisasi marang pendapatan Zynex, Inc. (ZYXI)|Multiplikator P/S ECOR|RBOT - Rega marang dodolan|Rasio rega marang pendapatan inspira-technologies.com IINN|IRIX: Rasio kapitalisasi marang pendapatan|INBS: Kapitalisasi marang pendapatan|beyondair.net - Kapitalisasi marang volume dodolan|Profusa Inc (PFSA) - Rasio rega marang pendapatan|SSKN - Koefisien rega marang pendapatan|Rasio rega marang pendapatan GlucoTrack|Multiplikator P/S NanoVibronix Inc.|Rasio rega marang pendapatan Venus Concept (VERO)|Kapitalisasi marang pendapatan Nuwellis, Inc. NUWE|Multiplikator P/S AEMD (Aethlon Medical, Inc.)|ASXC: Rasio kapitalisasi marang pendapatan|Avinger Inc. - Multiplikator P/S|Koefisien rega marang pendapatan BioSig Technologies, Inc BSGM|CUTR: Multiplikator P/S|Know Labs, Inc. (KNW) - Multiplikator P/S|Rasio rega marang pendapatan Inari Medical Inc|Kapitalisasi marang pendapatan Nevro Corp (NVRO)|Kapitalisasi marang pendapatan RSLS (ReShape Lifesciences, Inc.)|Multiplikator P/S Silk Road Medical Inc. (SILK)